U.S. market projected to grow from USD 2.45 billion in 2025 to USD 5.01 billion by 2035, while Europe is forecast to reach USD 4.02 billion amid rising adoption of transdermal therapeutics and vaccine ...

The review highlights nanocarriers, microspheres, hydrogels, microneedles, long-acting formulations, and co-formulations as ...

The shift toward patient-centric healthcare and self-administration technologies is driving significant growth, but ...

Controlled release drug delivery offers significant market opportunities by optimizing therapeutic effects and patient ...

A recent study published in Nature Communications showcased a breakthrough in transdermal drug delivery. Scientists have developed an electrically activated patch with biocompatible metallic membranes ...

Nanotechnology in drug delivery offers key market opportunities by enhancing drug precision, targeting challenging diseases, and improving patient care. The growing adoption is fueled by advancements ...

Controlled release systems deliver medication and other bioactive compounds to the ideal spot inside a body and over a specific time. New research from the University of Arkansas and the University of ...

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...

Please provide your email address to receive an email when new articles are posted on . The Control-IQ+ automated insulin delivery system was approved for use in pregnancy with the t:slim X2 and Mobi ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that its next-generation automated insulin delivery ...